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Sir,
The technique for percutaneous closure of atrial septal defect (ASD) is well described and has significantly improved since its inception. If the technique is strictly followed, the transcatheter closure may be safer than surgical closure of ASD, with successful acute closure in 97-100% of patients with a complication rate of <5%. Complications include atrial arrhythmia (2-4%), device embolization (3.5%), and pericardial effusion (0.5%). [1] Cardiac perforation is perhaps the most worrisome complication as it can sometimes occur many months to years after the procedure. [2] One of the reasons for acute on table perforation is related to the delivery cable of the device.
In our case, an 18-year-old boy who underwent successful transcatheter closure of ASD of size 18 mm using an Amplatzer ASD occluder of size 22 mm. He developed tamponade which was tapped successfully under fluoroscopic guidance. Retrospectively, we could clearly delineate that the pointed end of the delivery cable was quite far cephalad from delivery sheath just after the release of the ASD occluder [ Figure 1 and Video 1]. It is likely that the pointed end of delivery cable had perforated or created a small tear in the wall of right atrium. We feel that this a preventable complication needs to be highlighted so that the operator take necessary precautions to keep the delivery sheath very close to the tip of the delivery cable at the time of unscrewing the device which should be followed by an immediate pullback of the tip of the delivery cable into the sheath. Therefore, the operator should cautiously watch the position of the delivery sheath, the tip of the delivery cable and the position of the released device during deployment in addition to a close watch on vitals.
Delivery cable induced cardiac tamponade during transcatheter closure of atrial septal defect: A preventable complication Sir, We report a novel technique for transjugular device closure of a secundum atrial septal defect (ASD) in a 4-year-old, 20 kg child with an interrupted inferior vena cava (IVC) by using a "modified" short sheath. Transesophageal echo confirmed a secundum ASD with a diameter of 16 mm. Securing the wire position in a pulmonary vein was unable to be achieved after brief attempts. We decided to use a "modified" short sheath for device delivery. A 10 French, 11 cm sheath (Cook Medical Inc., Fort Worth, Texas, USA) was bent into a C-shape/half-moon shape and placed under cold saline to fixate the curve [ Figure 1 ]. This sheath was placed in the right internal jugular vein, and the wire and dilator were removed. The sheath was manipulated so that its distal end was placed just across the ASD into the left atrium [ Figure 2a and b]. A 20 mm Amplatzer septal occluder (St. Jude Medical, Inc., St. Paul, Minnesota, USA) was deployed with an excellent result [ Figure 3a and b].
Transhepatic, [1] transjugular, [2] and femoral [3] approaches have been reported to close a secundum ASD with an interrupted IVC and azygous continuation. During percutaneous secundum ASD closure in patients with an interrupted IVC, it is sometimes difficult to exchange a wire in a pulmonary vein for a stiff wire, from an internal jugular or femoral venous approach. While we certainly could have placed a wire in a pulmonary vein and performed balloon sizing and ASD closure, we chose to use our "modified" short sheath technique to enable a quicker procedure. We overcame these challenges by making a "C" shaped curve that facilitated the sheath position across the ASD into the left atrium. Keeping the tip of the sheath across the atrial septum into the left atrium is very critical in this technique. Although we manipulated the sheath without a dilator across the ASD, this technique can be employed by advancing the shaped sheath and dilator across a wire into the left atrium if stable wire position A novel technique for percutaneous closure of an atrial septal defect in a patient with interrupted inferior vena cava using a "modified" short sheath from an internal jugular vein approach
